Article
Give us your opinion on our latest poll, and see what your colleagues are saying. You can see the results of our previous surveys here as well.
FDA awards Regenerative Medicine Advanced Therapy Designation to CAN-2409 for prostate cancer
Pearls & Perspectives: From Guidelines to Practice—Navigating the TRT Treatment Spectrum, with Alex Tatem, MD
Subcutaneous nivolumab approved in EU, Canada for solid tumors
Pearls & Perspectives: Expanding BPH care & patient choice, with Kevin Zorn, MD, at AUA 25
Application submitted to FDA for 510(k) clearance of Men’s Sexual Health Test
Combination therapy linked to longer OS vs ADT in veterans with mHSPC
Intraprostatic drug elution therapy shows promise for BPH-related LUTS
Phase 3 trial of tebipenem HBr for cUTI stopped early for efficacy